Navigation Links
Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database
Date:7/31/2008

Agreement is first step towards collecting -- and analyzing -- data designed to provide better, more personalized cancer treatment

WASHINGTON and HAMBURG, Germany, July 31 /PRNewswire-USNewswire/ -- The field of personalized cancer research and treatment grows with each day. And a new partnership with Washington's largest biomedical research organization and an international research and biobanking company is contributing to that growth.

Georgetown University Medical Center announced today a partnership with Indivumed GmbH, based in Hamburg, Germany, designed to analyze complex clinical molecular signatures from cancer patients, enabling researchers and physicians to better diagnose and tailor cancer treatments for individual patients. The partnership builds upon a one-year agreement currently in place at Georgetown that established a high-quality tumor biobank and clinical database for pancreatic cancer and which, recently, also includes cancer of the breast and colon.

The expanded collaboration will grow to include a clinical database of prostate, glioblastoma and renal cancer. Together, the institutions expect to establish a robust portfolio of research collaborations, supported by a state-of-the-art biobanking infrastructure and protocol, using Indivumed's established scientific approach, and a multidimensional, integrated clinical and molecular database of cancer.

"Integrating scientific, medical, and technological expertise and assets will transform our ability to analyze complex clinical data relating to specific diseases, employing a more comprehensive, system-level approach to how we treat patients," says Howard J. Federoff, M.D., Ph.D., Executive Vice President for Health Sciences at GUMC. "We're starting with cancer, and hope this kind of research will lead to better, more individually targeted treatments."

The agreement will expand upon the Indivumed Biobank protocol already begun at Georgetown University Hospital, expanding the collection, storage, analysis and utilization of biospecimens. This includes prospective and standardized collection of pre-, intra- and post-surgical patient data and biospecimen data by specially trained research associates, extracting clinical data from existing clinical systems, developing an enhanced collaborative relationship with the MedStar Health system, Georgetown's clinical partner, and eventually developing partnerships with national health systems to establish a network of biobanking partnerships for specimen collection.

"Indivumed's approach to standardized and high-quality biobanking and data management as a foundation for individualized medical treatment aligns well with GUMC's approach to a Database of Cancer," says Dr. Hartmut Juhl, MD, CEO of Indivumed and former GUMC faculty member.

The collaboration is a key step in the future development of the Georgetown Database of Cancer (G-DOC) at Lombardi Comprehensive Cancer Center at Georgetown. The G-DOC will be designed to marry clinical information from patients in clinical trials with molecular characteristics of their cancer. This effort will define the molecular features that underlie prognosis and responsiveness to therapy in patients, providing a basis for personalized medicine and a tool for target discovery and drug development.

"Georgetown -- and its Lombardi Comprehensive Cancer Center -- is committed to reducing the burden of human cancer through the discovery and early adoption of cutting-edge systems' biology-based tools," says Louis M. Weiner, M.D., director, Lombardi Comprehensive Cancer Center. Lombardi is one of only 41 comprehensive cancer centers in the country and the only one in the Washington area. "Collaborating with a company with an established, successful research strategy such as Indivumed brings together the strengths of both institutions in order to achieve this goal."

Indivumed is a privately owned company started by former Georgetown faculty member Hartmut Juhl (Dr. Juhl continues to hold an adjunct faculty appointment at the University but is not compensated by Georgetown). Indivumed also has partnerships with 8 Clinical Cancer Centers in Hamburg, Germany, to collect similar specimens. Indivumed also has offices in Kensington, MD.

About Georgetown University Medical Center

Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through our partnership with MedStar Health). Our mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding.

About Indivumed

Indivumed is a privately held biotech company focused on the generation, characterization and analysis of highly standardized biological samples from human cancer for the development of individualized cancer therapies. Founded in 2002 and headquartered in Hamburg, Germany, with a subsidiary in Kensington, Maryland, USA, Indivumed has cooperation agreements with all major oncological hospitals in the Hamburg metropolitan area. Indivumed's clinical infrastructure and tumor biobank of currently more than 9,000 patient-cases serve as resources for both Indivumed's internal cancer biomarker discovery programs as well as for use by pharmaceutical and diagnostic partners through a variety of services, such as immunohistochemistry, drug profiling and access to biospecimen preparations linked with comprehensive clinical data.

About Lombardi Comprehensive Cancer Center

The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 39 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.


'/>"/>
SOURCE Indivumed
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New USAID grant helps Georgetown meet unmet family planning needs worldwide
2. Georgetown leads major effort to combat disparities in DC stroke care
3. Georgetown U student selected for prestigious Bouchet Society
4. Georgetown researchers find stem cell marker controls 2 key cancer pathways
5. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
6. Georgetown Medical Center collaborates to develop cancer research database
7. University of Iowa professor identifies new eating disorder
8. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
9. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
10. Tulane University to receive $14M for international HIV/AIDS program
11. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Milford, NJ (PRWEB) , ... December 02, 2016 , ... ... Nothing Water has some unique properties including its unmatched natural purity of just 6 ... as clean and crisp. , Nothing Water has been available in several ShopRite and ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
(Date:11/30/2016)... PALMYRA, Wisconsin (PRWEB) , ... November 30, 2016 ... ... inclusion in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of ... consecutive year on the list, having ranked from 2008-2016. In addition, Standard Process ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and stylish design wanted by today’s consumers at an affordable price, is now ... says the new watch is “a game changer” when it comes to the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... in the ECG Cables And ECG Leadwires Market owing to ... devices. On the other hand, the Asia-Pacific ... rate during the forecast period. The market players ... plc ( Ireland ), Koninklijke Philips N.V. ( ... ( China ), held major share of the ...
(Date:12/2/2016)... PUNE, India , December 2, 2016 /PRNewswire/ ... research report "In Vitro Diagnostics/IVD Market by Product ... Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious ... the global market is valued at USD 60.22 ... grow at a CAGR of 5.5% during the ...
(Date:12/2/2016)... On Thursday, December 1st 2016, ... research, development and innovation in the biopharmaceutical industry at ... in the presence of Sergey Tsyb, Vice Minister of ... , Natalia Sanina, First Vice Chairman of the ... of Roszdravnadzor, National Service of Control in Healthcare, Sergey ...
Breaking Medicine Technology: